Wednesday, June 6, 2012

Margin Notes | The top three hoary metaphors of the higher-ed ...

The top three hoary metaphors of the higher-ed apocalypse

Posted on 5 June 2012 by L?o Charbonneau

Post to Twitter

The three horsemen -- uh, hoary metaphors -- of the coming higher-ed apocalypse.

To read about higher education today, one might get the impression that the whole ivy-covered edifice is on shaky ground, ready to collapse. Universities are certainly facing big challenges, but much of what?s being said seems to me wildly pessimistic. The metaphors used to describe this parlous state I find particularly amusing.

To be fair, most of the commentary I highlight below is in reference to the U.S. higher education system, but some Canadian commenters have parroted these same arguments when talking about the problems facing Canada?s system, so I think it?s fair game to cite them here. Forthwith, I present my top three hoary metaphors of the higher-ed apocalypse.

1. Higher education is a bubble waiting to pop.

Borrowing an economic metaphor, several commentators have claimed that higher education is overpriced relative to its value, and once people figure this out the education market will crash, much like the U.S. housing market did in 2008 and the dot-com craze before that. The higher-ed bubble hypothesis seems to have been first articulated early in 2011 in an article on the website Tech Crunch, quoting hedge fund manager and venture capitalist Peter Thiel. The idea was quickly picked up by the Economist, New York magazine (great photo!) and others.

The Economist?s Schumpeter blog summarizes Thiel?s argument this way:

?Tuition costs are too high, debts loads are too onerous, and there is mounting evidence that the rewards are over-rated. Add to this the fact that politicians are doing everything they can to expand the supply of higher education ? much as they did everything that they could to expand the supply of ?affordable? housing, and it is hard to see how we can escape disaster.?

The bubble metaphor has not gone unchallenged. Good arguments popping the bubble myth can be found in Inside Higher Ed, the Chronicle of Higher Education, Fast Company ?and Slate.

2. Higher education is like the dying newspaper industry.

Picking up on some of the themes above, Thomas Kunkel, the president of St. Norbert College in De Peer, Wisconsin, explains the parallels:

?Both the newspaper industry and higher education have largely failed to recognize the Internet as an emerging competitive threat or a useful tool to be exploited. Both have been reluctant to innovate their core products. Indeed, both have operated in a kind of self-constructed bubble, assuming they can conduct business the way they always have?by imposing lavish price increases as if it were a sovereign right, for instance, or taking a young-adult audience for granted. And both newspapers and higher education have imagined they would be around forever.?

Kevin Carrey, who interestingly didn?t support the bubble hypothesis in the Chronicle link above, does support the dying newspaper industry analogy. He writes in a 2009 post: ?Both industries are in the business of creating and communicating information. Paradoxically, both are threatened by the way technology has made that easier than ever before.?

Bonus: universities have also been compared to the dying automobile industry, the bankrupt Kodak film company and the now-shuttered Borders Bookstores.

3. Higher education is heading for the ?Great Disruption.?

The Great Disruption meme (complete with Upper Caps) was popularized by Michael Staton, CEO of the U.S. company Inigral. Supporting the higher-education bubble theme, he argued last September that the current business model of universities is broken. Others have used the Great Disruption metaphor in reference to how online education is going to wipe out the traditional universities as we know them, prompting the Atlantic magazine to envision a post-campus America. Globe and Mail columnist Margaret Wente picked up on the Great Disruption meme, opining that the current university model ?has reached the end of the line in Canada, too.?

As proof that the Great Disruption is nigh, many commentators point to the success of the ?Stanford education experiment,? which saw 160,000 people sign up for a free, online Introduction to Artificial Intelligence course taught by its professors Sebastian Thrun and Peter Norvig. Meanwhile, Harvard and MIT recently announced they?ll offer free online courses through a project called edX, while a number of other universities ? including Stanford ? will do the same through Coursera. Two New York Times columnists have waxed poetic about this coming shake-up in higher education: Thomas Friedman (?Come the Revolution?) and David Brooks (?The Campus Tsunami?).

This has led to some remarkable hyperbole, such as Professor Thrun prophesizing that in 50 years, there will be only 10 institutions in the world delivering higher education; or a Forbes columnist who suggests that mass online education will make 90 percent of the professoriate obsolete with the next 20 years.

Perhaps I?m mistaken, but I just don?t see this burgeoning demand for online education, at least not among the key segment of full-time undergraduate students. I side with Alex Usher of the Canadian firm Higher Education Strategy Associates, who states emphatically: ?There. Is. No. Great. Disruption. Coming. In. Higher. Education. Period.? His reasoning:

?Yes, there are some very interesting educational experiments going on out there. But does any of this amount to a serious challenge to universities? Does any of it make it more likely that 18- to 24-year-olds will abandon schools to go take courses online? No, because apart from some marginal techno-freaks, everyone thinks education is a social activity, which requires a much richer set of interactions than is possible online. ? The new technology does make certain types of education ? essentially continuing education and certain types of professional development ? less costly and more convenient. And to a certain clientele (but not 18- to 24-year-olds) this matters. But this clientele is pretty marginal at most universities, so it?s hard to see why institutions would face some kind of disruptions.?

(You may also wish to read the recent thoughts of Alan Slavin on this topic elsewhere on our site.)

Finally, this crisis talk is, of course, not really new. Peter Drucker is quoted in Forbes in 1997 as saying, ?Thirty years from now the big university campuses will be relics. Universities won?t survive. It [Internet technology] is as large a change as when we first got the printed book ? the system is rapidly becoming untenable.? He still has 15 years to be proven right. Any bets?

unemployment rate jesse ventura keri russell drew barrymore bill o brien portland trailblazers will kopelman

Tuesday, June 5, 2012

New 'Personalized' Drugs Show Promise Against Melanoma, Lung Cancer

MONDAY, June 4 (HealthDay News) -- There's more encouraging news from the brave new world of "personalized" cancer care, with three drugs showing promise against some of the most common cancers.

Two studies to be presented Monday at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago focus on drugs that treated advanced melanoma, while a third study looks at a gene-targeted chemotherapy for a subset of lung cancers.

All of the drugs seemed effective in these phase 3 trials.

Already, targeted medications such as these "are of use in the metastasis [cancer] setting," said ASCO spokeswoman Dr. Sylvia Adams, who moderated a press briefing Sunday on the new trials.

"In advanced lung cancer, advanced melanoma, [targeted therapies] are the standard of care," said Adams, an assistant professor in the department of medicine at NYU's Langone Medical Center in New York City.

In the past, doctors gave cancer drugs to patients generally, in the hopes that at least some of the patients would respond. Nowadays, personalized medicine is "a more patient-focused approach that targets treatments to the genetic abnormality in cancers that drive cancer growth," Adams explained.

The idea is that if a patient's tumor tests positive for a certain cancer-linked genetic mutation, then a drug targeting that aberration should help. On the other hand, if the patient's cancer does not carry that gene flaw, he or she can be spared trying out the medication.

One trial reported on at the ASCO meeting on Monday included 322 patients with a form of advanced melanoma that involves so-called BRAF mutations.

The patients -- who had already received at least one round of chemotherapy -- were randomly assigned to receive standard chemotherapy (either dacarbazine or paclitaxel) or an experimental drug called trametinib.

Trametinib targets a particular point in the same cell-signaling pathway that includes BRAF, so it was hoped that the drug would short-circuit this pathway and help slow tumor growth.

According to study co-author Dr. Caroline Robert, a professor of dermatology at Institut Gustave Roussy in France, the drug did seem to work for many of these tough-to treat patients.

At the press briefing, she said there was a "very significant difference" in outcomes for patients on trametinib compared to those on standard therapy. For example, median survival without tumor progression was pegged at 4.8 months for those on the experimental drug, versus 1.5 months for those on standard chemo. Patients on the newer drug also had a 46 percent reduced risk for death compared to those on the standard regimen, Robert said.

That survival advantage might even be higher, Robert noted, since so many patients on standard therapy opted to "cross over" midway through the trial to get trametinib instead.

This study, funded by drug maker GlaxoSmithKline, was also published simultaneously June 4 in the New England Journal of Medicine.

In a second phase 3 melanoma trial presented at the ASCO meeting, 345 patients with untreated, inoperable late-stage melanomas were randomly assigned to either the experimental, BRAF-targeted drug dabrafenib or the standard chemotherapy, dacarbazine.

Survival without tumor progression averaged more than five months for those on the new drug, compared to 2.7 months for people on the older therapy. Half of patients on dabrafenib responded to treatment, compared to just 6 percent of those on standard chemo, the researchers reported.

Side effects did occur but were seldom serious and only 3 percent of patients discontinued their use of dabrafenib, according to study author Dr. Axel Hauschild, a professor of dermatology at University Hospital in Kiel, Germany.

Speaking at the news briefing, Hauschild said that "the next step is [trying] a combination of dabrafenib and trametinib" for patients with these BRAF-sensitive melanomas.

Finally, a third study looked at another gene-targeted compound against non-small cell lung cancers, the most common form of the disease. The drug, afatinib, inhibits two types of gene aberrations in the epidermal growth factor receptor [EGFR], a key focus of current lung cancer research.

A total of 345 patients with advanced, EGFR-sensitive lung cancers were given either afatinib or standard chemotherapy. Those on the new drug saw a significant jump in terms of survival without disease progression -- an average of 11 months, versus just under seven months for those on standard chemo. And for the subset of 308 patients with the most common EGFR mutations, progression-free survival nearly doubled, to 13.6 months.

Lung cancer symptoms such as cough and shortness of breath also declined in people on the new drug. Overall, patients on afatinib "had better quality of life and better symptom control than with [standard] chemotherapy," study author Dr. James Chih-Hsin Yang, of National Taiwan University Hospital, said at the press briefing.

According to ASCO spokeswoman Adams, these studies "promise to expand the range of effective and targeted therapies for patients with common cancers."

Findings presented at medical meetings are typically considered preliminary unless (as with the trametinib trial) they are also published in a peer-reviewed journal.

More information

Find out more about gene-targeted therapies at the U.S. National Cancer Institute.

austin rivers sweet home alabama etch a sketch the host hoodie hoosiers temperance

Saturday, June 2, 2012

Android Central international round-up - June 2, 2012

Android Central

It's been another busy week for international Android news. The week's biggest story was undoubtedly the European Galaxy S III launch -- Samsung's latest flagship is now available on hundreds of carriers across the continent. (In "marble white" for now, as the "pebble blue" variant faces delays of 2-3 weeks.) As for the Galaxy S III in the U.S., the latest rumors suggest a possible June 20 launch, but that's yet to be confirmed.

We also got another European first this week -- the arrival of the Orange San Diego, Europe's first Intel-powered smartphone. And our own Richard Devine was on hand to give us his first impressions.

Other notable developments included HTC's launch of the Desire C on Three UK, and the arrival of long-awaited Ice Cream Sandwich updates for the Sony Xperia Arc and Xperia Neo, as well as HTC's Sensation XL.

And earlier on in the week, we reviewed the Sony Xperia U, an interesting little mid-range device from the Japanese manufacturer. Right now we're in the process of bringing you our definitive Galaxy S III review, so keep watching in the days ahead. In the meantime, we've got your full international round-up below...

Special features:

News:

If you've got international news, be sure to tip us at the usual address.



kansas vs kentucky joe posnanski michael kidd gilchrist national championship calipari national archives brock lesnar

Tuesday, May 29, 2012

Mickelson joins group trying to buy Padres

San Diego Padres' Nick Hundley, left, high-fives teammate Chase Headley after Headley hit a solo home run during the fourth inning of a baseball game against the Chicago Cubs, Monday, May 28, 2012 in Chicago. (AP Photo/Brian Kersey)

San Diego Padres' Nick Hundley, left, high-fives teammate Chase Headley after Headley hit a solo home run during the fourth inning of a baseball game against the Chicago Cubs, Monday, May 28, 2012 in Chicago. (AP Photo/Brian Kersey)

(AP) ? Phil Mickelson wants to be more than just a fan of the San Diego Padres. He wants to help buy the team.

Mickelson said Monday he has a joined one of the five groups trying to buy the team from John Moores, the Padres' majority owner for the last 18 years. Mickelson is part of the group that includes four grandchildren of former Los Angeles Dodgers owner Walter O'Malley ? Kevin and Brian O'Malley, and their cousins Peter and Tom Seidler, the chief executive of Class A Visalia Rawhide.

"I've been talking to them about being involved with them, having an opportunity to invest in the team and being part of the ownership group," Mickelson said. "I think it's a very good investment opportunity. More than that, it's opportunity to be involved in the community in San Diego, with something that gives the community a sense of pride. I feel like we can make the Padres a competitive team that can contend year in and year out, and we can do something for the community.

"It's something I've loved since I was a kid."

The San Diego Union-Tribune first reported the involvement of Mickelson, a four-time major champion who was inducted this month into the World Golf Hall of Fame. Mickelson brings the O'Malley clan a local investor and of San Diego's greatest athletes.

San Diego's biggest baseball star ? another lefty ? is involved in another group trying to buy the Padres. Tony Gwynn said last week he is joining the bid led by Thomas Tull, chairman and CEO of Legendary Entertainment.

"When we met with Phil we were inspired by his commitment to San Diego and his passion for the Padres," Kevin O'Malley said in a statement to the Union-Tribune. "He is a world-class person, athlete and businessman with a strong history of charitable leadership and he will be an ideal partner for many years in San Diego."

Mickelson said he was asked to get involved in an ownership bid three years ago, but didn't feel it was a good fit.

"I think the O'Malley and Seidler family is the right group," he said. "They want to enhance the community tie, and that's something I've wanted to be part of, as well. The tie between the community and the team has not been as strong as it has been in the past. I think there are some things where we can increase that relationship, the emotional tie with the community and the players."

Moores' proposed sale of the team to Jeff Moorad collapsed in March after baseball owners refused to approve Moorad as controlling owner. Moorad headed a group that in March 2009 agreed to a gradual takeover of the Padres. At the time, the deal was estimated to be worth around $500 million.

The Padres could be worth a few hundred million more this time, in light of the Dodgers being sold for a record $2 billion and the Padres' new TV deal with Fox.

Moores owns 51 percent while Moorad's group owns 49 percent.

Asked about his proposed investment, Mickelson said only that it would be "a lot," and that it would be a "significant investment opportunity."

As for his role?

"Day-to-day operations, running a sports organization, that's not my forte," Mickelson said. "I want to have a personal relationship with the players and find ways to get them tied to the community, things of that nature."

Associated Press

nebraska football online deals leap pad lauren alaina lowes best buy black friday frys ad

Sunday, May 27, 2012

Project Glass: First video shot with Google glasses

? Gear Live Inc. ? User-posted content, unless source is quoted, is licensed under a Creative Commons Public Domain License. Gear Live graphics, logos, designs, page headers, button icons, videos, articles, blogs, forums, scripts and other service names are the trademarks of Gear Live Inc.

chuck series finale welcome back kotter 2001 a space odyssey barefoot bandit polar bear plunge lovelace antioch

Secure Baldwin Park Plumbing Pursuits You Can Do On Your Own ...

If they display up on time and do a very good job, I am one content camper. I usually appear to be in the middle of some big venture and calling a person to arrive support me. I adore a property in good doing work buy and I like our property to appear good and be somewhat updated. I am home all day and I continuously see factors that require to be accomplished. One day I went from space to room and make a checklist two pages long of all the little items to be fixed, painted, mounted or patched.

A residence is a continual transform project there is usually one thing to repair or restore, but that is what makes property ownership a challenge and interesting.

Loads of individuals favor to do plumbing maintenance on they are. They do it for many reasons: sensation of accomplishment, lesser bills and for learning encounter. It is enjoyable to try to do Diy plumbing on your possess. However, there are limitations as to what you can and can?t do basically simply because not all routines for plumbing is secure to do Diy.

There can be various varieties of plumbing difficulties. You can attempt to correct them all but you can never be too positive if you will be profitable in the conclude. Some of them are actually advanced that it will certainly want some abilities and expertise to be fastened. You may know the principles but it wouldn?t be ample to get issues carried out. Rather, you will be just caught up in a lemon.

If you want to start off correcting up these issues, do these that are manageable. The target is to fix issues and not to trigger more hurt or even set you at risk. If you go over and above your ability, you may possibly end up breaking what is already damaged and this can turn out to be expensive for you.

Below are some examples of simple plumbing maintenance that you can do:

1. Repairing a shower head- This must be a piece of cake. The moment you buy the established, you can uncover the manufacturer?s instructions on how to install it. No need to have to phone for a plumber. All you need for these repair are wrenches and compounds.

2. Caulking fixtures in the toilet- There may possibly be a time when the caulk on your bathtub and other toilet fixtures. As a consequence, water can leak from the cracks and ultimately result in much more injury as the composition weakens. For this reason, you can just re-utilize the caulking substance like silicon or a precise caulk for the fixture currently being repaired. Deliver out your knife and other cutting supplies, wiping fabrics, cleansing options and chlorine. Re-caulking is effortless and does not require intense pursuits.

3. Unclogging clogged drains and bathroom- It does not need to have a genius to do this. You can just open the drain and remove debris causing the clog. If it is nevertheless stubborn you can pump it out the whole. If it is just some minor clogs, you can attempt to use options for dissolving.

4. Faucet Substitution- As soon as in a even though, your taps would appear to its end of daily life. When this transpires, it wouldn?t complete near, leading to water to ongoing drip. Envision the gallons of water you are throwing away if you do not act on this problem appropriate absent.

Are you in need of Baldwin Park Plumbing for a home improvement project? Have you sprung a leak at home or at work? We deliver you a experienced expert technicians which can fix every kind of commercial and residential plumbing complications.

Related Posts:

ufc 144 james jones james jones aladdin black forest ufc 144 fight card ufc 144 results

Saturday, May 26, 2012

Egos And Immorality

The New York Times:

If Wall Streeters are spoiled brats, they are spoiled brats with immense power and wealth at their disposal. And what they're trying to do with that power and wealth right now is buy themselves not just policies that serve their interests, but immunity from criticism.

Read the whole story at The New York Times

Contribute to this Story:

"; var coords = [-5, -72]; // display fb-bubble FloatingPrompt.embed(this, html, undefined, 'top', {fp_intersects:1, timeout_remove:2000,ignore_arrow: true, width:236, add_xy:coords, class_name: 'clear-overlay'}); });

nathan hale kohls coupons joe kapp joe kapp kohls target target